They also detected unique N-glycosylation patterns of CD44, MGAM, and GINM1 that varied between non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) patients which could potentially be linked with the progression of bladder cancer [28]. This evidence concerns the gene CD44 and urinary bladder cancer.